Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model.

作者: Saiedeh Razi Soofiyani , Tohid Kazemi , Farzaneh Lotfipour , Akbar Mohammad hosseini , Dariush Shanehbandi

DOI: 10.3109/21691401.2015.1129618

关键词: Cancer researchImmunohistochemistryCancerTransfectionLipofectamineImmunotherapyGenetic enhancementPathologyInterleukin 12FibrosarcomaMedicine

摘要: Context Immunotherapy is among the most promising modalities for treatment of cancer. Recently, interleukin 12 (IL-12) has been used as an immunotherapeutic agent in cancer gene therapy. IL-12 can activate dendritic cells (DCs) and boost anti-tumor immune responses. Objective In current study, we have investigated if therapy lead to regression tumor mass a mouse model fibrosarcoma. Material methods To investigate therapeutic efficacy IL-12, WEHI-164 were transfected with murine-IL12 plasmids using Lipofectamine. Enzyme linked immunosorbent assay (ELISA) was confirm expression cells. The fibrosarcoma established by subcutaneous injection Balb/C mice. Mice sacrificed tumors extracted. Tumor sizes measured caliper. IFN-γ studied real-time PCR western blotting. Ki-67(a proliferation marker) immunohistochemistry staining. Results discussion group treated showed significant decrease volume (P: 0.000). results blotting that increased (relative IL-12: 1.9 relative IFN-γ: 1.766). Immunohistochemistry staining Ki-67 reduced IL-12. Conclusion successfully led regress model. This may serve candidate approach

参考文章(41)
Luni Emdad, Mitchell E Menezes, Swadesh K Das, Devanand Sarkar, Santanu Dasgupta, Shilpa Bhatia, Paul B Fisher, Xiang-Yang Wang, Innovative approaches for enhancing cancer gene therapy. Discovery Medicine. ,vol. 15, pp. 309- 317 ,(2013)
Surendar Reddy Bathula, Leaf Huang, Gene Therapy with Plasmid DNA Burger's Medicinal Chemistry and Drug Discovery. pp. 457- 499 ,(2010) , 10.1002/0471266949.BMC073.PUB2
Jeffrey A. Sosman, Nicholas J. Vogelzang, Lynn J. Buchanan, Matthew L. Sherman, Michael B. Atkins, Janice P. Dutcher, John P. Leonard, John L. Ryan, Gerald L. Fisher, Glenn Larsen, Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12–Associated Toxicity and Interferon-γ Production Blood. ,vol. 90, pp. 2541- 2548 ,(1997) , 10.1182/BLOOD.V90.7.2541
Christine C. Conwell, Leaf Huang, Recent advances in non-viral gene delivery. Advances in Genetics. ,vol. 53, pp. 1- 18 ,(2005) , 10.1016/S0065-2660(05)53001-3
Ursula Pertl, Andrew D. Luster, Nissi M. Varki, Dirk Homann, Gerhard Gaedicke, Ralph A. Reisfeld, Holger N. Lode, IFN-γ-Inducible Protein-10 Is Essential for the Generation of a Protective Tumor-Specific CD8 T Cell Response Induced by Single-Chain IL-12 Gene Therapy The Journal of Immunology. ,vol. 166, pp. 6944- 6951 ,(2001) , 10.4049/JIMMUNOL.166.11.6944
Sally Lehrman, Virus treatment questioned after gene therapy death Nature. ,vol. 401, pp. 517- 518 ,(1999) , 10.1038/43977
J. Cohen, IL-12 Deaths: Explanation and a Puzzle Science. ,vol. 270, pp. 908- 908 ,(1995) , 10.1126/SCIENCE.270.5238.908A
Cancer immunotherapy: Progress and challenges in the clinical setting. European Journal of Immunology. ,vol. 41, pp. 1510- 1515 ,(2011) , 10.1002/EJI.201190035
Z P Shen, A A Brayman, L Chen, C H Miao, Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery Gene Therapy. ,vol. 15, pp. 1147- 1155 ,(2008) , 10.1038/GT.2008.51
Shulin Li, Xueqing Xia, Francesca M Mellieon, Jianguo Liu, Stacy Steele, Candidate Genes Associated with Tumor Regression Mediated by Intratumoral Il-12 Electroporation Gene Therapy Molecular Therapy. ,vol. 9, pp. 347- 354 ,(2004) , 10.1016/J.YMTHE.2003.11.022